REPL Q1 2026 Earnings NarrowerThanExpected Loss as Pipeline Progress Continues Mineralys Therapeutics MLYS Q1 2026 Earnings Narrowerthanexpected Loss as Clinical Progress Continues SAIC Q1 2026 Earnings Strong EPS Surprise Drives Stock Higher MaxCyte Q1 2026 Earnings EPS Beat Highlights Operational Cost Discipline Amid Revenue Disclosure Gaps EHTH Q1 2026 Earnings EPS Misses Estimates Sharply as Losses Deepen FURY Earnings Overview 20260525